Undervalued Small Caps In United States With Insider Buying To Consider

Simply Wall St.
2024-09-24

Over the last 7 days, the United States market has risen 1.2%, and over the past 12 months, it is up by a notable 30%. In this promising environment where earnings are forecast to grow by 15% annually, identifying undervalued small-cap stocks with insider buying can present compelling opportunities for investors.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name PE PS Discount to Fair Value Value Rating
Columbus McKinnon 20.4x 0.9x 43.91% ★★★★★★
Hanover Bancorp 9.4x 2.2x 48.86% ★★★★★☆
Citizens & Northern 13.2x 2.9x 42.39% ★★★★☆☆
MYR Group 33.5x 0.5x 43.58% ★★★★☆☆
Franklin Financial Services 9.9x 2.0x 37.58% ★★★★☆☆
Vital Energy 4.3x 0.6x -48.01% ★★★☆☆☆
Delek US Holdings NA 0.1x -232.01% ★★★☆☆☆
Community West Bancshares 18.7x 2.9x 42.25% ★★★☆☆☆
Orion Group Holdings NA 0.3x -108.51% ★★★☆☆☆
Industrial Logistics Properties Trust NA 0.7x -253.37% ★★★☆☆☆

Click here to see the full list of 51 stocks from our Undervalued US Small Caps With Insider Buying screener.

Let's dive into some prime choices out of from the screener.

Phibro Animal Health

Simply Wall St Value Rating: ★★★★★☆

Overview: Phibro Animal Health is a company that develops, manufactures, and markets a broad range of animal health and mineral nutrition products, with a market cap of approximately $0.57 billion.

Operations: Phibro Animal Health generates revenue primarily from three segments: Animal Health, Mineral Nutrition, and Performance Products. The company reported a gross profit margin of 30.82% for the quarter ending June 30, 2024. Operating expenses in the same period were $254.27 million, with non-operating expenses amounting to $56.93 million.

PE: 368.7x

Phibro Animal Health, a smaller U.S. company, has seen insider confidence with recent share purchases in the past quarter. Despite a dip in profit margins to 0.2% from 3.3% last year, earnings are forecasted to grow by 51.46% annually. Recent guidance for fiscal year 2025 projects net sales between US$1.04 billion and US$1.09 billion, driven by growth in its Animal Health segment and recovery in Mineral Nutrition and Performance Products segments.

  • Unlock comprehensive insights into our analysis of Phibro Animal Health stock in this valuation report.
  • Review our historical performance report to gain insights into Phibro Animal Health's's past performance.

NasdaqGM:PAHC Share price vs Value as at Sep 2024

Columbus McKinnon

Simply Wall St Value Rating: ★★★★★★

Overview: Columbus McKinnon is a company specializing in machinery and industrial equipment with operations generating approximately $1.02 billion in revenue.

Operations: Machinery & Industrial Equipment generated $1.02 billion in revenue for the latest period. Gross profit margin has shown an upward trend, reaching 37.08% recently.

PE: 20.4x

Columbus McKinnon, a smaller U.S. company, has shown potential for growth with earnings forecast to increase by 29.84% annually. Despite the recent executive change with Jon Adams stepping in as President of Americas post-September 2024, the company remains steady. They reported Q1 sales of US$239.73 million and net income of US$8.63 million, slightly down from last year’s figures but still solid performance indicators. Insider confidence is evident through share purchases within the past six months, reflecting optimism about future prospects despite current financial challenges like high-risk funding sources and modest dividend payouts at $0.07 per share.

  • Dive into the specifics of Columbus McKinnon here with our thorough valuation report.
  • Evaluate Columbus McKinnon's historical performance by accessing our past performance report.

NasdaqGS:CMCO Share price vs Value as at Sep 2024

PRA Group

Simply Wall St Value Rating: ★★★★★☆

Overview: PRA Group is a financial services company specializing in the purchase and collection of nonperforming loans, with a market cap of approximately $1.42 billion.

Operations: The company generates revenue primarily from accounts receivable management, with operating expenses and non-operating expenses being significant cost components. Notably, the net income margin has shown fluctuations, reaching as high as 23.85% and dipping to -10.40% in recent periods.

PE: 217.6x

PRA Group's recent earnings report shows a significant turnaround, with Q2 2024 revenue at US$284.23 million, up from US$209.24 million the previous year, and net income of US$21.52 million compared to a net loss of US$3.8 million a year ago. Insider confidence is evident as Independent Director Geir Olsen purchased 11,750 shares worth approximately US$251,332 in June 2024, increasing their holdings by over 250%. This activity suggests optimism about the company's future performance despite its recent drop from several Russell indexes and board changes.

  • Click here to discover the nuances of PRA Group with our detailed analytical valuation report.
  • Examine PRA Group's past performance report to understand how it has performed in the past.

NasdaqGS:PRAA Share price vs Value as at Sep 2024

Key Takeaways

  • Discover the full array of 51 Undervalued US Small Caps With Insider Buying right here.
  • Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
  • Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Curious About Other Options?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGM:PAHC NasdaqGS:CMCO and NasdaqGS:PRAA.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10